SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 19, 2026

BCRX

BIOCRYST PHARMACEUTICALS INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago
Insider cluster: 2 insiders, $697K total
Actionable Insight • Neutral

The insider sales are routine and immaterial in size. The CLO's sale is a standard cashless exercise pattern, and the director's sale is small. No bearish signal from this cluster. Monitor for any material insider purchases or changes to ORLADEYO prescription trends in the next quarterly update.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.74
T+0 close · May 19, 2026 · via day close
Latest settled
+11.44%
T+60 · $9.74
Vs SPY
+6.44%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 20 $8.74entry
  2. T+1 · 6mo ago −4.23%α −4.43% · $8.37
  3. T+5 · 6mo ago +4.35%α +3.11% · $9.12
  4. T+20 · 5mo ago +2.86%α +2.12% · $8.99
  5. T+60 · 3mo ago +11.44%α +6.44% · $9.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two BioCryst insiders sold a total of $697K in open-market sales within a week of Q1 2026 earnings. The CLO exercised 62,500 options at $5.04 and immediately sold the shares at $9.54 for a $596K profit; a director sold 11,180 shares for $100K. The cluster value is ~0.03% of the $2.3B market cap, well below the 0.1% materiality threshold, and the CLO's sale is a routine cashless exercise pattern. The earnings filing showed in-line ORLADEYO revenue and maintained guidance, providing no bearish catalyst.

Key Financial Metrics

Direction
selling
Total Value
$697.0K
Insiders
2

Key Facts

  • Chief Legal Officer Barnes exercised 62,500 options at $5.04 and sold the shares at $9.54 for $596K on 2026-05-13
  • Director McKee sold 11,180 shares at $8.97 for $100K on 2026-05-18
  • Total insider sales of $697K represent ~0.03% of BCRX's $2.3B market cap
  • Q1 2026 ORLADEYO revenue of $148.3M (+11% YoY) was in line with maintained FY2026 guidance of $625-645M
  • Non-GAAP operating profit of $54.2M; GAAP net loss of $721.8M driven by non-cash Astria acquisition charge
  • No open-market purchases in the cluster; all sales are either cashless option exercises or small director sales

Financial Impact

Insider sales of $697K are trivial relative to $2.3B market cap (0.03%)

dilutioninsider ownership

Risk Factors

  • No bearish risk from this cluster; sales are too small to signal adverse information
  • Q1 GAAP net loss of $721.8M is non-cash and not operationally concerning
  • Navenibart Phase 3 enrollment completion by June 2026 is a key catalyst to watch

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BCRX-1779221310869

Track record

20 reports on BCRX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.01% at T+20 after the Feb 26, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.71 Now $7.45 −3.35% settles Feb 16
  2. Nov 13, 20263d ago Press Release Neutral 3/10 Entry $7.61 Now $7.45 −2.10% settles Feb 11
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $7.53 Now $7.45 −1.06% settles Feb 8
  4. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  5. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $8.24 Now $7.45 −9.59% settles Feb 2
  6. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $8.57 Now $7.45 −13.07% settles Feb 1
  7. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $8.37 Now $7.45 −10.99% settles Jan 26
  8. Oct 21, 202626d ago Press Release Neutral 1/10 Entry $7.78 Now $7.45 −4.24% settles Jan 20
  9. Aug 5, 202614w ago 8-K Bullish 7/10 Entry $9.07 to $8.46 Now $7.45 −17.86% ▼ −6.73% −6.92% vs SPY
  10. Jun 29, 202620w ago 8-K Neutral 5/10 Entry $9.55 to $8.78 Now $7.45 −21.99% ▼ −8.06% −12.45% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026